Cleo Diagnostics Ltd (COV) — Net Asset Quality Index
Cleo Diagnostics Ltd (COV) has a Net Asset Quality Index of 88.6% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of AU$9.96 Million minus total liabilities of AU$1.14 Million yields net assets of AU$8.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. See COV days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cleo Diagnostics Ltd Net Asset Quality Index Over Time (2022–2025)
This chart shows how Cleo Diagnostics Ltd's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the index stands at 88.6%, representing net assets of AU$8.83 Million against total assets of AU$9.96 Million AUD. Explore Cleo Diagnostics Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Cleo Diagnostics Ltd (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Cleo Diagnostics Ltd from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Cleo Diagnostics Ltd.
| Year | Quality Index | Net Assets (AUD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.1% | AU$5.83 Million | AU$6.94 Million | AU$1.10 Million | ▼ -11.0 pp |
| 2024 | 95.1% | AU$9.39 Million | AU$9.88 Million | AU$486.22K | ▲ +182.7 pp |
| 2023 | -87.6% | AU$-943.41K | AU$1.08 Million | AU$2.02 Million | ▼ -70.3 pp |
| 2022 | -17.4% | AU$-42.28K | AU$243.61K | AU$285.89K | — |